Bariatric Surgery Combined With GLP-1 Receptor Agonists Study (NCT07336862) | Clinical Trial Compass
RecruitingPhase 1/2
Bariatric Surgery Combined With GLP-1 Receptor Agonists Study
China200 participantsStarted 2024-01-01
Plain-language summary
Obese patients exhibit considerable heterogeneity and complex comorbidities, making long-term effective management challenging with single therapies. While bariatric surgery remains the most effective weight-loss intervention, postoperative weight regain and metabolic deterioration require attention. GLP-1 RAs offer distinct advantages for weight and metabolic improvement, and their combined application with surgery may yield synergistic benefits. This study investigates the efficacy and safety of bariatric surgery combined with GLP-1 receptor agonist adjuvant therapy for severe obesity.
Who can participate
Age range18 Years – 60 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.